Lungren Matthew 4
4 · Lumexa Imaging Holdings, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Lumexa (LMRI) Director Matthew Lungren Receives 19,358 RSUs
What Happened
Matthew Lungren, a director of Lumexa Imaging Holdings, was granted 19,358 restricted stock units (RSUs) on June 10, 2026. The award is reported as an acquisition (code A) at $0.00 per RSU (no cash paid by the reporting person). Each RSU represents the contingent right to one share of Lumexa common stock.
Key Details
- Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (filed within the standard two-business-day window).
- Grant: 19,358 RSUs, acquisition price reported as $0.00.
- Shares owned after the transaction: not specified in the information provided in this summary.
- Footnote (F1): RSUs vest on the earlier of the one‑year anniversary of the grant date and the next annual meeting of stockholders, subject to Lungren’s continued service.
- Transaction code: A (award/grant). Exhibit included: Power of Attorney (Exhibit 24).
Context
RSU grants are a form of equity compensation; they do not involve an immediate cash purchase or sale and vest over time subject to service conditions. Such awards are common for directors and executives and are not, by themselves, a direct market signal of buying or selling intent.
Insider Transaction Report
Form 4
Lungren Matthew
Director
Transactions
- Award
Common Stock
[F1]2026-06-10+19,358→ 19,358 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.
Signature
/s/ Paul Gilbert, attorney-in-fact|2026-06-12